Andere Sprachen ABL Diagnostics

Aktien

A3DL82

FR001400AHX6

ABLD

Markt geschlossen - Euronext Paris Andere Börsenplätze 11:30:21 03.05.2024			% 5 Tage	% 1. Jan.
3,14 ^EUR	+1,29 %		+8,28 %	-67,63 %

2023	ABL Diagnostics Société anonyme meldet Ergebnis für das Halbjahr bis zum 30. Juni 2023	CI
2023	ABL Diagnostics Société anonyme meldet Ergebnis für das am 31. Dezember 2022 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

ABL DIAGNOSTICS : MISE EN PLACE D’UN CONTRAT DE LIQUIDITE AVEC ALLINVEST SECURITIES	23.04.
AdvancedDx Biological Laboratories USA Inc. and Medline Industries, LP to distribute Next Generation Sequencing (NGS) Prep Kits in the U.S.	17.04.
AdvancedDx Biological Laboratories USA Inc. expands its logistics and storage capacity for supporting and managing third-parties' clinical trials in the USA	16.04.
ABL Diagnostics appoints PALEX to offer NGS genotyping applications & Sanger to microbiology laboratories in Spain.	18.03.
Block trading of ABL Diagnostics ordinary shares (ABLD, Euronext, compartment B)	04.03.
Carrying Out Research About HIV Whole Genome using a Kit Now Available in the USA	28.02.
ABL Diagnostics and AB ANALITICA join forces to offer microbiology genotyping solutions in Italy.	28.02.
AdvancedDx Biological Laboratories USA Inc. announces its new temperature-controlled warehouse in the USA	20.02.
ABL Diagnostics announces the release of its DeepChek®-HPV Assay, to be used for Human Papillomavirus screening, genotyping, and discrimination through sequencing.	18.01.
ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	21.12.
ABL DIAGNOSTICS INTRODUCING CRISPRCHEK - A NEW LINE OF ASSAYS USING THE CRISPR TECHNOLOGY	18.12.
ABL Diagnostics releases new applications for respiratory viruses including Influenza, RSV and SARS-CoV-2	06.12.
ABL DIAGNOSTICS EXPANDS ITS HIV GENOTYPING ASSAYS OFFERING	30.11.
ABL Diagnostics expands its commercial network and collaborations to offer unique Sanger & NGS based microbiology genotyping assays and software worldwide.	24.11.
ABL Diagnostics : Document AMF CP. 2023DD925593	01.09.23
ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2022	01.08.23
Roche, ABL Diagnostics Sign Distribution Partnership in South Africa	27.03.23
Roche Diagnostics (Pty) Ltd and ABL Diagnostics enter into an Exclusive Distribution Agreement in South Africa	27.03.23
ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2022	02.09.22
Advanced Biological Laboratories S.A. completed the acquisition of a 96.7% stake in ABL Diagnostics Société anonyme (ENXTPA : ABLD) from STE Parisienne De Construction Et De Location and seven natural persons.	31.08.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen ABL Diagnostics

Aktien

A3DL82

FR001400AHX6

ABLD

Andere Sprachen

Filter